Amylyx Pharmaceuticals, Inc. (AMLX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q1'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | -665K | 416K | -1.02M | 88.64M | 108.45M | 102.69M | 98.22M | 71.43M | 21.89M | 345K | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | 100% | -100% | 100% | -100% | -100.61% | -99.59% | -101.04% | 24.1% | 395.54% | 29666.09% | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 98K | 108K | 19.86M | 141K | 0 | 0 | 809K | 7.63M | 116.41M | 9.36M | 5.22M | 5.58M | 5.28M | 2.82M | 172K | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | 194.47% | -745.45% | 131.32% | 8.63% | 5.08% | 5.68% | 7.4% | 12.89% | 49.86% | - | - | - | - | - |
| Gross Profit | -98K | -108K | -19.86M | -141K | 0 | -665K | -393K | -8.65M | -27.76M | 99.09M | 97.47M | 92.64M | 66.14M | 19.06M | 173K | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | 100% | -94.47% | 845.45% | -31.32% | 91.37% | 94.92% | 94.32% | 92.6% | 87.11% | 50.14% | - | - | - | - | - |
| Gross Profit Growth % | - | 83.76% | -4952.16% | 98.37% | 100% | -100.67% | -100.4% | -109.34% | -141.97% | 419.77% | 56243.93% | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 43.78M | 36.5M | 16.17M | 42.72M | 37.8M | 39.99M | 75.27M | 44.79M | 94.37M | 97.16M | 78.75M | 72.44M | 68.2M | 63.66M | 54.85M | 54.25M | 47.81M | 28.32M | 22.92M | 12.87M |
| OpEx % of Revenue | - | - | - | - | - | -6013.38% | 18093.27% | -4377.91% | 106.46% | 89.59% | 76.69% | 73.75% | 95.48% | 290.87% | 15899.71% | - | - | - | - | - |
| Selling, General & Admin | 16.17M | 15.39M | 16.17M | 15.64M | 15.68M | 17.1M | 17.83M | 21.65M | 57.76M | 52.24M | 48.72M | 43.39M | 44.01M | 40.84M | 29.94M | 29.99M | 26.35M | 14.92M | 10.35M | 6M |
| SG&A % of Revenue | - | - | - | - | - | -2570.98% | 4285.58% | -2116.03% | 65.16% | 48.17% | 47.44% | 44.18% | 61.61% | 186.63% | 8678.26% | - | - | - | - | - |
| Research & Development | 27.61M | 21.11M | 19.86M | 27.08M | 22.12M | 22.89M | 21.24M | 23.14M | 36.61M | 44.91M | 30.04M | 29.04M | 24.19M | 22.81M | 24.91M | 24.26M | 21.46M | 13.39M | 12.85M | 6.86M |
| R&D % of Revenue | - | - | - | - | - | -3442.41% | 5105.05% | -2261.88% | 41.3% | 41.41% | 29.25% | 29.57% | 33.87% | 104.24% | 7221.45% | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | -1000K | 0 | 0 | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -285K | 0 |
| Operating Income | -43.78M | -36.6M | -36.03M | -42.86M | -37.8M | -40.65M | -75.66M | -53.44M | -122.13M | 1.93M | 18.72M | 20.2M | -2.05M | -44.59M | -54.68M | -54.25M | -47.81M | -28.32M | -22.92M | -12.87M |
| Operating Margin % | - | - | - | - | - | 6113.38% | -18187.74% | 5223.36% | -137.78% | 1.78% | 18.23% | 20.57% | -2.87% | -203.76% | -15849.57% | - | - | - | - | - |
| Operating Income Growth % | -15.81% | 9.96% | 52.38% | 19.8% | 69.05% | -2202.07% | -504.17% | -364.52% | -5848.86% | 104.34% | 134.23% | 137.23% | 95.71% | -57.49% | -138.59% | - | - | - | - | - |
| EBITDA | -43.68M | -36.5M | -35.91M | -42.72M | -37.65M | -40.49M | -75.44M | -53.23M | -121.81M | 2.23M | 19.02M | 20.48M | -1.85M | -44.41M | -54.52M | -54.15M | -47.78M | -28.29M | -22.91M | -12.86M |
| EBITDA Margin % | - | - | - | - | - | 6089.32% | -18134.62% | 5203.03% | -137.42% | 2.06% | 18.52% | 20.85% | -2.59% | -202.93% | -15801.74% | - | - | - | - | - |
| EBITDA Growth % | -16.03% | 9.87% | 52.4% | 19.75% | 69.09% | -1911.81% | -496.59% | -359.87% | -6488.16% | 105.03% | 134.89% | 137.83% | 96.13% | -56.97% | -137.98% | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 98K | 108K | 120K | 141K | 156K | 160K | 221K | 208K | 315K | 301K | 302K | 281K | 204K | 182K | 165K | 105K | 35K | 22K | 10K | 10K |
| EBIT | -43.78M | -31.06M | -34.39M | -41.44M | -37.8M | -40.65M | -75.66M | -53.44M | -122.13M | 1.93M | 18.72M | 20.2M | -2.05M | -44.59M | -54.68M | -54.25M | -47.81M | -28.34M | -22.92M | -12.87M |
| Net Interest Income | 2.57M | 3.29M | 1.82M | 1.96M | 2.23M | 2.32M | 3.1M | 4.07M | 4.33M | 4.37M | 4.18M | 3.89M | 3.72M | 3.16M | 601K | 402K | 131K | 30K | 3K | 2K |
| Interest Income | 2.57M | 3.29M | 1.82M | 1.96M | 2.23M | 2.32M | 3.1M | 4.07M | 4.33M | 4.37M | 4.18M | 3.89M | 3.72M | 3.16M | 601K | 402K | 131K | 30K | 3K | 2K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.5M | 3.65M | 1.64M | 1.41M | 1.9M | 2.47M | 2.96M | -19.27M | 3.58M | 4.54M | 3.69M | 3.81M | 3.46M | 2.47M | 800K | 360K | 112K | -29K | -224K | -1.66M |
| Pretax Income | -41.28M | -32.95M | -34.39M | -41.44M | -35.91M | -38.18M | -72.7M | -72.7M | -118.55M | 6.48M | 22.41M | 24.01M | 1.4M | -42.13M | -53.88M | -53.89M | -47.7M | -28.34M | -23.14M | -14.52M |
| Pretax Margin % | - | - | - | - | - | 5741.5% | -17476.92% | 7106.55% | -133.74% | 5.97% | 21.82% | 24.44% | 1.96% | -192.48% | -15617.68% | - | - | - | - | - |
| Income Tax | 0 | 46K | 0 | 0 | 0 | -635K | 0 | 0 | 242K | 1.75M | 1.52M | 1.93M | -170K | 579K | -125K | 174K | 146K | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -0.14% | 0% | 0% | 0% | 1.66% | 0% | 0% | -0.2% | 26.95% | 6.77% | 8.05% | -12.12% | -1.37% | 0.23% | -0.32% | -0.31% | 0% | 0% | 0% |
| Net Income | -41.28M | -33M | -34.39M | -41.44M | -35.91M | -37.55M | -72.7M | -72.7M | -118.79M | 4.73M | 20.89M | 22.07M | 1.57M | -42.7M | -53.76M | -54.07M | -47.85M | -28.34M | -23.14M | -14.52M |
| Net Margin % | - | - | - | - | - | 5646.01% | -17476.92% | 7106.55% | -134.01% | 4.36% | 20.35% | 22.48% | 2.2% | -195.13% | -15581.45% | - | - | - | - | - |
| Net Income Growth % | -14.97% | 12.11% | 52.7% | 42.99% | 69.77% | -893.62% | -447.98% | -429.35% | -7652% | 111.08% | 138.87% | 140.83% | 103.29% | -50.66% | -132.29% | - | - | - | - | - |
| Net Income (Continuing) | -41.28M | -33M | -34.39M | -41.44M | -35.91M | -37.55M | -72.7M | -72.7M | -118.79M | 4.73M | 20.89M | 22.07M | 1.57M | -42.7M | -53.76M | -54.07M | -47.85M | -28.34M | -23.14M | -14.52M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.37 | -0.28 | -0.37 | -0.46 | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.30 | 0.31 | 0.02 | -0.65 | -0.92 | -0.93 | -0.93 | -0.51 | -0.42 | -0.32 |
| EPS Growth % | 11.9% | 49.09% | 65.42% | 57.01% | 76% | -904.09% | -456.67% | -445.16% | -7982.88% | 110.52% | 132.61% | 133.33% | 102.39% | -27.45% | -119.05% | - | - | - | - | - |
| EPS (Basic) | -0.37 | -0.28 | -0.37 | -0.46 | -0.42 | -0.55 | -1.07 | -1.07 | -1.75 | 0.07 | 0.31 | 0.33 | 0.02 | -0.65 | -0.92 | -0.93 | -0.93 | -0.51 | -0.42 | -0.32 |
| Diluted Shares Outstanding | 110.56M | 94.57M | 93.33M | 89.14M | 85.7M | 68.59M | 68.09M | 68.02M | 67.85M | 69.2M | 69.75M | 70.13M | 70.86M | 65.42M | 58.53M | 58.28M | 51.6M | 55.22M | 55.22M | 45.95M |
| Basic Shares Outstanding | 110.56M | 94.57M | 93.33M | 89.14M | 85.7M | 68.59M | 68.09M | 68.02M | 67.85M | 67.41M | 67.41M | 67.23M | 66.72M | 65.42M | 58.53M | 58.14M | 51.45M | 55.22M | 55.22M | 45.95M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |